Background. Recent advances in miniaturization of phased-array and mechanical ultrasound devices have resulted in exploration of alternative approaches to cardiac and vascular imaging in the form of transesophageal or intravascular imaging. Preliminary efforts in adapting phased-array endoscopes designed for transesophageal use to a transvascular approach have used full-sized phased-array devices introduced directly into the right atrium in open-chested animals. The purpose of this study was to assess the feasibility of using a custom-made, very small phased-array endoscope for intracardiac imaging introduced intravascularly through a jugular venous approach in young piglets.
ageal and intravascular windows for echocardiographic and Doppler interrogation. [1] [2] [3] [4] Although intracoronary imaging has been viewed as an important aid to making decisions about modes of treatment for coronary disease and can provide guidance during or after coronary balloon angioplasties or performance of other atherotomy techniques, pediatric cardiologists have been more interested in exploring imaging technologies that would be more feasible in the guidance of interventional catheterization procedures such as balloon valvuloplasties, dilatations of aortic coarctations or other central vascular stenoses, and placement of transcatheter devices used for closing patent ductus arteriosus and atrial and ventricular septal defects. To 
Results
Studies were performed in close-chest piglets that lay on their backs while anesthetized with ketamine (10-20 mg/kg); breathing was spontaneous, without endotracheal intubation or mechanical ventilation.
The imaging probe was advanced through a cutdown incision of the external jugular vein and into the right atrium without difficulty. Once in the right atrium, the probe required minimal rotation superiorly and inferiorly to visualize all intracardiac structures and flows with excellent resolution.
Both atria, atrioventricular valves, and ventricles were imaged in detail. Flows were recorded from the vena cava and the pulmonary veins, across both atrioventricular valves, and through both ventricular outflows and great vessels ( Figure 1 ).
In all four piglets, the atrial septal defect closure devices were identified, and the position of each within the atrial septum was defined easily. The device was positioned well in three of the four piglets ( Figure 2A ). Flow was recorded with color Doppler mapping around the tips of both the occluder and counteroccluder in two of the piglets (Figures 2B and  2C ). In the fourth piglet, the occluder was partially pulled through the defect into the right atrium, and a small clot was seen at the bottom of the device just above the tricuspid valve. No residual flow through the atrial septal defects was recorded in any of the four piglets.
All findings related to device placement were confirmed by fluoroscopy and postmortem examination of the heart. No damage was found in the heart or veins as a result of the probe. Preliminary efforts in adapting phased-array endoscopes for transvascular use have involved the introduction of full-sized phased-array devices directly into the right atrium in open-chest animals.1" With the recent success in further miniaturizing these phased-array probes, investigators have turned their attention to assessing the feasibility of introducing these probes transvascularly. Seward et al12 described preliminary findings with intracardiac imaging obtained by manipulating a small esophageal echocardiographic transducer within the aorta and the inferior vena cava of normal pigs. Introduction of these catheters through the external jugular venous system would make this procedure somewhat analogous to that used with bioptomes to perform endocardial biopsies, although the sizes of these imaging endoscopes still exceed those of biopsy catheters.
A number of technological advances expected to be available within the near future should facilitate significant miniaturization of these probes. Increasing transducer interrogation frequency to 7.5 and potentially 10 MHz for sector scan-format phasedarray technologies would result in a 30% to 50% decrease in array size, even with the same number of elements, such that a 3-mm, 20-element phased array could be built for longitudinal scanning. Efforts in our laboratory on a National Institutes of Healthsponsored technology development program are aimed in that direction. 13 Further, in addition to changes in the configuration of the phased-array scan head itself, there are also new, smaller, more densely packed and shielded coaxial cables that might aid in reducing shaft diameter.13 For intracardiac scanning from the right atrium, it is still probably advisable to have steerability to aim the array at different areas of the heart, but metallic alloy materials that change shape when temperature varies or when low-voltage electrical current is applied could be used to bend or flex the tip of the probe. This system would be less cumbersome and smaller than the cable system presently used in ultrasonic esophagoscopes. Last, radially arranged arrays or mechanically steered singlecrystal catheters are available at 20 MHz and at lower frequencies,1415 but these technologies have not been implemented with the capability of color flow imaging or waveform Doppler. There are technical difficulties related to the coded aperture reconstructions used for radial array catheter scanners that may limit high spatial resolution at larger distances from the transducer or limit their capability for deriving waveform or color Doppler. We expect, however, that miniaturization of probes and increases in frequencies to 7.5-10 MHz should permit the eventual introduction of phased-array devices through a femoral venous approach; these improvements should increase the ease of use of this type of intravascular ultrasonic monitoring in the cardiac catheterization laboratory and allow for human application, eventually even in children.
